Research Centers of Excellence
Dr. Gabriel G. Malouf MD, PhD provides a good overview of rare kidney cancers at the molecular level for patients and physicians.
Presented at the 2016 GUASCO conference in San Francisco
Due to their small population, few resources and fewer clinical trials are devoted exclusively to patients with rare kidney cancer (also call "non clear cell renal cell carcinoma" or nccRcc).
Clemson's Colin Targonski, M. Reed Bender, Benjamin T. Shealy, Benafsh Husain, Melissa C. Smith and F.
James Hsieh's latest Interview
I received this question two days ago on SmartPatients.com "What do your docs say about Pap type 1?"
Good question. Here is my detailed response.
"So far, NO improvement in outcome over the last decade."
No partners have been featured.
Copyright © 2016